A person’s “bioenergetic age”-or how youthfully their cells generate energy-might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.
Biologic Therapy for IBD Not Tied to Higher Risk of Major Heart Events
In contrast to recent data on tofacitinib (Xeljanz) in rheumatoid arthritis, patients with inflammatory bowel disease (IBD) who received biologic therapies appeared to have a